Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Royal College of Physicians of London.
Working Party Reports. Osteoporosis. Clinical guidelines for prevention and treatment, (2001),
[2.]
World Health Organisation.
Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. WHO Technical Report Series.
[3.]
National Institutes of Health.
Osteoporosis and related bone diseases National Resource Centre. Osteoporosis overview, (1999),
[4.]
R.M. Francis.
Metabolic bone disease.
Brocklehurst's textbook of geriatric medicine and gerontology, pp. 1137-1154
[5.]
Department of Health.
Strategy to prevent and tackle osteoporosis, (2001),
[6.]
J. Compston.
Update on the RCP's guidelines on osteoporosis.
Osteoporosis Review, 9 (2001), pp. 7-9
[7.]
R.C. Herings, B.H. Stricker, A. de Boer, et al.
Benzodiazepines and the risk of falling leading to femur fractures.
Arch Intern Med, 155 (1995), pp. 1801-1807
[8.]
R.M. Leipzig, R.G. Cummings, M.E. Tinetti.
Drugs and falls in older people: a systematic review and metaanalysis: 1. Psychotropic drugs.
J Am Geriatr Soc, 47 (1999), pp. 30-39
[9.]
B. Ettinger, D.M. Black, B.H. Mitlak, R.K. Knickerboker, T. Nickelsen, H.K. Genart, et al.
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3-year randomised clinical trial.
JAMA, 282 (1999), pp. 637-645
[10.]
P.D. Delmas, N.H. Bjarnason, B.H. Mitlak, A.C. Pavoux, A.S. Shah, W.S. Huster, et al.
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
N Engl J Med, 337 (1997), pp. 1641-1647
[12.]
A.M. Sutcliffe.
Nurse-run osteoporosis clinic.
Osteoporosis review, 9 (2001), pp. 6-8
[13.]
Department of Health.
Making a difference. Strengthening the nursing, midwifery and health visiting contribution to health and healthcare.
London, DoH, (1999),
Copyright © 2003. Sociedad Española de Geriatría y Gerontología
